Other

Cost of prior grants of restricted stock units (“RSUs”), performance share units (“PSUs”) and stock appreciation rights (“SARs”) that are amortized over their applicable vesting periods

JPMorgan Chase Cost of prior grants of restricted stock units (“RSUs”), performance share units (“PSUs”) and stock appreciation rights (“SARs”) that are amortized over their applicable vesting periods increased by 26.4% to $440.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.8%, from $424.00M to $440.00M.

Analysis

StatementIncome Statement
SectionOther
First reportedQ1 2015
Last reportedQ1 2026May 1, 2026
Metric ID: other_share_based_compensation_amortization_of_prior_gra_189fc6

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$280.00M$283.00M$271.00M$378.00M$292.00M$357.00M$449.00M$363.00M$435.00M$430.00M$359.00M$424.00M$380.00M$348.00M$440.00M
QoQ Change+1.1%-4.2%+39.5%-22.8%+22.3%+25.8%-19.2%+19.8%-1.1%-16.5%+18.1%-10.4%-8.4%+26.4%
YoY Change+35.0%+3.2%+31.7%+18.8%+24.3%+21.8%-4.2%-1.1%-2.5%-11.6%-3.1%+3.8%
Range$271.00M$449.00M
CAGR+13.8%
Avg YoY Growth+9.7%
Median YoY Growth+3.5%

Frequently Asked Questions

What is JPMorgan Chase's cost of prior grants of restricted stock units (“rsus”), performance share units (“psus”) and stock appreciation rights (“sars”) that are amortized over their applicable vesting periods?
JPMorgan Chase (JPM) reported cost of prior grants of restricted stock units (“rsus”), performance share units (“psus”) and stock appreciation rights (“sars”) that are amortized over their applicable vesting periods of $440.00M in Q1 2026.
How has JPMorgan Chase's cost of prior grants of restricted stock units (“rsus”), performance share units (“psus”) and stock appreciation rights (“sars”) that are amortized over their applicable vesting periods changed year-over-year?
JPMorgan Chase's cost of prior grants of restricted stock units (“rsus”), performance share units (“psus”) and stock appreciation rights (“sars”) that are amortized over their applicable vesting periods increased by 3.8% year-over-year, from $424.00M to $440.00M.